Andrew Booth - 03 Jun 2026 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Reporting relationship: Chief Financial Officer
Issuer ticker: ABCL
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 14:23:16 UTC
Prior SEC filing: 27 Feb 2026
Next SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: Tryn Stimart, attorney-in-fact

Key filing fact

Andrew Booth filed Form 4 for AbCellera Biologics Inc. (ABCL) on 03 Jun 2026.

Key facts

This page summarizes Andrew Booth's Form 4 filing for AbCellera Biologics Inc. (ABCL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2026, 14:23.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001834411 Primary reporting owner

Booth Andrew

Relationship: Chief Financial Officer
Address: C/O ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA
Signature: Tryn Stimart, attorney-in-fact
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABCL transaction

Common Shares

Options Exercise

Transaction value
Shares: +250,000
Change %: +128%
Price: $0.1900^*
Shares after: 445,600
Date: 03 Jun 2026
Ownership: Direct

ABCL holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 130,959
Date: 03 Jun 2026
Ownership: By spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABCL transaction Derivative

Share option (right to buy)

Options Exercise

Transaction value
Shares: -250,000
Change %: -2.9%
Price: $0.000000^*
Shares after: 8,501,849
Date: 03 Jun 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 250,000
Exercise price: $0.1900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.